Los Angeles, CA 10/14/13—Affymetrix has sold its Anatrace business to StoneCalibre, an investment firm specializing in the acquisition of lower middle market companies, for an undisclosed amount. Anatrace develops, manufactures and distributes high purity detergents and synthetic lipids for use in membrane protein studies. “Anatrace is a high quality company offering a value-add product that […]

Heysham, UK 9/16/13—Research chemicals provider Alfa Aesar has bought Biomedical Technologies (BTI). BTI product lines include specialty proteins, cell culture additives and immunoassay tools. “The acquisition of BTI brings protein research and characterization, all types of profiling tools and certain separation technologies and provides opportunities for Alfa Aesar to leverage BTI’s manufacturing capabilities to enhance […]

Kobe, Japan 9/24/13—Diagnostics firm Sysmex has acquired Partec, a German provider of flow cytometers for research and diagnostic applications, for an undisclosed amount. Sysmex plans to leverage its sales and support network to increase Partec sales, as well as combine flow cytometry with its hematology offerings. In fiscal 2012, Partec had sales of €20.1 million […]

Newton, NJ and Westwood, MA 10/7/13—Photonics product manufacturer Thorlabs has acquired CompuCyte, the supplier of the Laser Scanning Cytometry technology for high content cellular and tissue-based analysis, for an undisclosed amount. CompuCyte’s iCyte, iCys and iColor instruments incorporate non-confocal laser scanner imaging technology. “The acquisition of the CompuCyte product lines is an important step forward […]

Aubagne, France 10/7/13—Sartorius Stedim Biotech has made a cash offer to acquire UK-based TAP Biosystems. The offer values the equity of TAP at approximately €33 million ($45 million = €0.74 = $1). TAP designs and develops small scale, multi-parallel fermentation systems, automated cell processing systems and other benchtop equipment. “Adding capabilities in the early steps […]

Tokyo, Japan and New York, NY 9/27/13; Osaka, Japan 9/27/13—Panasonic has agreed to sell its Healthcare business to investment firm Kohlberg Kravis Roberts & Co. (KKR) for approximately $1.67 billion. Following the sale, Panasonic will purchase 20% of outstanding shares in the new company. Panasonic Healthcare consists of three businesses: In Vitro Diagnostics, Medicom and […]

Company Announcements Roche Diagnostics’ second quarter sales of qPCR and NAP (nucleic acid purification) Systems increased 6%. Fiscal first quarter sales ending June 30 for Hitachi High-Technologies Science and Medical Systems (SMS) fell 18.0% to ¥29,100 million ($294.5 million) to account for 22% of revenues (see IBO 7/31/13). Biotechnology, Medical and Electron Microscopes declined 26.2%, […]

Washington, DC 8/20/13; San Diego, CA 9/23/13—Sequenom has announced it is reviewing potential strategic alternatives for its Genetic Analysis business. In addition, last month, the company announced in an SEC filing a cost reduction effort that includes the termination of approximately 75 employees. The company expects to record $10 million in compensation-related expenses in future […]

Engham, UK 9/30/13; Amesbury, UK 9/30/13; Malvern, UK 9/30/13—Spectris’s Malvern Instruments business, which provides instrumentation for materials and biophysical characterization, has acquired NanoSight for £15 million ($24 million = £0.62 = $1) net of debt and cash acquired. NanoSight’s Nanoparticle Tracking Analysis technology enables the simultaneous multi-parameter analysis and characterization of different types of nanoscale […]

Menlo Park, CA 9/25/13; Washington DC 9/25/13—Sequencer maker Pacific Biosciences has announced an agreement with Roche Diagnostics to develop and manufacture diagnostic products, including sequencing systems and consumables. The products will be sold exclusively to Roche, which will distribute them in the human IVD field. Pacific Biosciences retains rights for all other fields. “We are […]